Only the SRC-2 gene demonstrated a marginal significance for the diagnostic performance of high-risk PCa, with an AUC of 0.59 (95% CI 0.498–0.696; p = 0.060; Supplementary Material 4A). This evidence concerns the gene NCOA2 and posterior cortical atrophy.